Filing Details
- Accession Number:
- 0001493152-18-015218
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-05 18:00:14
- Reporting Period:
- 2018-11-02
- Accepted Time:
- 2018-11-05 18:00:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100397 | Advaxis Inc. | ADXS | Pharmaceutical Preparations (2834) | 841521955 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1576077 | Robert Petit | 305 College Road East Princeton, NJ 08540 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-11-02 | 8,491 | $0.56 | 235,169 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- In connection with the vesting of 28,826 shares on April 2, 2018, a total of 8,491 of such shares were withheld by the Company in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.